Status:
COMPLETED
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Lead Sponsor:
Fox Chase Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cervical Cancer
Precancerous Condition
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
RATIONALE: Mindfulness-based stress reduction (MBSR) may reduce patient stress and improve quality of life. It is not yet known whether mindfulness-based stress reduction is effective in improving imm...
Detailed Description
OBJECTIVES: * To evaluate the effects of a standardized mindfulness-based stress reduction (MBSR) intervention versus a diet and physical activity program on psychosocial well-being (e.g., perceived ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Referred for a colposcopy following an abnormal Pap smear test result
- Atypical squamous cells of undetermined significance/positive for human papilloma virus or mild to moderate dysplasia
- Referred for a second opinion OR patient of record within the medical practice who is undergoing routine recommended follow-up
- Recruited from Fox Chase Cancer Center or Thomas Jefferson University Hospital
- No history of cervical cancer
- No evidence of present invasive carcinoma
- PATIENT CHARACTERISTICS:
- Must be able to read and/or communicate in English
- Not pregnant
- No known HIV positivity
- No psychiatric disorder or other disorder that would preclude informed consent
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT00653146
Start Date
September 1 2007
End Date
July 1 2014
Last Update
December 5 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States, 19107-5541
2
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, United States, 19111-2497